Skip to content
Screener

Upstream Bio, Inc. UPB Q1 2025 earnings

Reported May 6, 2025 · Before market open

Revenue$566.0KBeat by $249.0K
EPS-$0.51Miss by $0.02
Revenue estimate$317.0K
EPS estimate-$0.49

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$522.5K
EPS estimate-$0.73

Financials

Q1 2025

Income statement

See full
Revenue$566.0K-11.6%
Operating income-$32.0M-113%
Net income-$27.3M-150%
EPS (diluted)-$0.51+89.1%

Balance sheet

See full
Cash & equivalents$71.3M+126%
Total debt$1.7M—
Total equity$445.6M+434%
Total assets$456.2M—

Cash flow

See full
Operating cash flow-$41.2M-134%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$328.28M—
Enterprise value$258.67M—
P/S143×—

Profitability

See full
Operating margin-4,127.4%—
Net margin-3,448.7%—

Returns & leverage

See full
Debt / equity0×—
Current ratio47.4×—

FAQ

When did Upstream Bio, Inc. report Q1 2025 earnings?
Upstream Bio, Inc. (UPB) reported Q1 2025 earnings on May 6, 2025 before market open.
What were Upstream Bio, Inc.'s Q1 2025 revenue and EPS?
Upstream Bio, Inc. reported revenue of $566.0K and eps of $-0.51 for Q1 2025.
Did Upstream Bio, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $317.0K by $249.0K. EPS missed the consensus estimate of $-0.49 by $0.02.
Where can I find Upstream Bio, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-063954) and the 10-Q periodic report (0000950170-25-063957) directly on SEC EDGAR. The filing index links above go to sec.gov.